X Bioscience PCL (BKK:XBIO)

X Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.19	26.75	16.16	28.01	43.42
Cash & Short-Term Investments	9.19	26.75	16.16	28.01	43.42
Cash Growth	-65.63%	65.57%	-42.33%	-35.48%	-19.22%
Accounts Receivable	34.63	0.59	3.71	5.07	3.71
Other Receivables	15.6	28.56	14.12	18.19	11.04
Receivables	50.23	29.15	17.83	23.26	14.75
Inventory	11.87	6.76	13.09	35.12	20.23
Prepaid Expenses	3.19	1.43	1.54	3.28	2.62
Other Current Assets	32.69	7.09	6.51	9.8	8.69
Total Current Assets	107.17	71.19	55.12	99.47	89.71
Property, Plant & Equipment	596.29	213.87	173.56	294.62	226.12
Goodwill	335.35	246.18	267.44	516.1	516.1
Other Intangible Assets	319.23	146.54	150.05	364.85	414.37
Long-Term Deferred Tax Assets	0.13	-	-	-	-
Other Long-Term Assets	56.17	61.6	53.92	45.55	34.24
Total Assets	1,414	739.39	700.09	1,321	1,281
Accounts Payable	46.65	28.22	29.54	71.01	35.52
Accrued Expenses	39.3	38.33	25.24	17.5	10.17
Short-Term Debt	251.86	293.24	340.34	301.54	66.96
Current Portion of Long-Term Debt	3.05	3.05	3.21	3.14	1.44
Current Portion of Leases	22.16	26.64	27.23	36.39	23.25
Current Unearned Revenue	6.12	1.68	0.38	0.3	0.83
Other Current Liabilities	64.14	35.02	31.17	28.05	21.14
Total Current Liabilities	433.26	426.2	457.12	457.94	159.31
Long-Term Debt	5.93	8.29	10.68	13.2	9.47
Long-Term Leases	71.57	83.81	91.51	114.78	100.36
Long-Term Unearned Revenue	-	-	-	-	0.02
Long-Term Deferred Tax Liabilities	64.88	27.88	29.01	34.65	40.3
Other Long-Term Liabilities	5.88	7.15	6.94	19.66	16.78
Total Liabilities	586.93	556.58	597.55	647.19	332.44
Common Stock	1,944	1,031	813.91	813.91	12,209
Retained Earnings	-1,376	-1,116	-968.77	-397.91	-939.72
Comprehensive Income & Other	-53.66	268.5	257.4	257.4	-10,321
Total Common Equity	513.52	182.8	102.54	673.4	948.1
Minority Interest	313.91	0	0	0	0
Shareholders' Equity	827.43	182.81	102.54	673.41	948.11
Total Liabilities & Equity	1,414	739.39	700.09	1,321	1,281
Total Debt	354.56	415.04	472.98	469.05	201.48
Net Cash (Debt)	-345.37	-388.29	-456.82	-441.04	-158.06
Net Cash Per Share	-0.27	-0.44	-0.56	-0.54	-0.23
Filing Date Shares Outstanding	1,944	1,031	813.91	813.91	813.91
Total Common Shares Outstanding	1,944	1,031	813.91	813.91	813.91
Working Capital	-326.09	-355.01	-402	-358.47	-69.6
Book Value Per Share	0.26	0.18	0.13	0.83	1.16
Tangible Book Value	-141.06	-209.92	-314.95	-207.55	17.63
Tangible Book Value Per Share	-0.07	-0.20	-0.39	-0.26	0.02
Land	126	-	-	-	-
Machinery	354.01	70.33	72.44	123.46	101.12
Construction In Progress	8.56	16.51	2.3	11.08	3.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.